MC2 Therapeutics A/S: Financial statements 2020
CVR: 29526346
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
MC2 Therapeutics A/S (CVR 29526346) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 15,938,167 and a net result of DKK -86,940,654 compared with DKK -81,401,184 the year before. That is an increase of 16.5% compared with the year before. Equity in the 2020 report amounted to DKK 13,930,183. The solvency ratio was 38.5%.
- Gross Profit
- DKK 15,938,167
- Profit/Loss
- DKK -86,940,654
- Equity
- DKK 13,930,183
- Total Assets
- DKK 36,144,891
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 15.9 mio. | -86.9 mio. | 13.9 mio. | - |
| 2019 | - | 13.7 mio. | -81.4 mio. | 65.8 mio. | 11 |
| 2018 | - | 13.3 mio. | -110.1 mio. | 62.3 mio. | 10 |
| 2017 | - | 10.3 mio. | -79.1 mio. | 30.9 mio. | 8 |
| 2016 | - | 6.8 mio. | -40.1 mio. | 54.4 mio. | 5 |
Official annual report
How creditworthy is MC2 Therapeutics A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of September 14, 2020, Paul Louis Berns has left the board of directors of MC2 Therapeutics A/S.
MC2 Therapeutics A/S has published its annual report for 2019. Gross profit came to DKK 13,678,382, and the net result was DKK -81,401,184.
About MC2 Therapeutics A/S
MC2 Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named MC2 Therapeutics ApS and MC2 BIOTEK ApS. The management consists of Trine Ahlgreen. The board consists of Mads Jørgen Nøhr Clausen (chair), Anders Dahlgaard Hove, John Sørensen Haurum and Tomas Dahl Mikkelsen. The company is owned by Alsmark Invest II ApS, MC2 HOLDING ApS and Selskabet af 4. april 2023 ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 22,248,504 and a net result of DKK -7,816,954 compared with DKK -53,006,931 the year before. Equity in the 2025 report amounted to DKK -224,478,927.